Increasing competition, changing regulatory requirements and higher demand fluctuations are pushing pharmaceutical manufacturers to boost their productivity and product quality. To meet their expectations, Neyret Group has developed a new type of direct-to-object machine based on inkjet printing. This approach was not obvious because pad printing, which ensures very precise image transfers onto three-dimensional surfaces, is the process of choice for direct-to-object machines in the pharmaceutical industry. But this process has a major drawback for machine productivity: the pads need to be changed quite often, thereby causing frequent machine downtimes. By contrast, inkjet printing enables printing of digital-based images directly to the object surface, eliminating these productivity losses.